Release Date: 22/01/20 14:37 Summary: Status of Re-Compliance Listing on ASX Price Sensitive: No Download Document 970.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%